Valuation
Is the price right?3/3 inputs reported · High confidence
Mixed versus peers:
- ▲ Earnings yield
- ▼ EBITDA yield
Behind the score
Sector-normalized EBITDA, earnings, and free cash flow yields.
Bringing the fundamentals into focus…
Price as of close on Oct 5, 2026 · Financials updated Oct 6, 2026
3/3 inputs reported · High confidence
Mixed versus peers:
Sector-normalized EBITDA, earnings, and free cash flow yields.
3/3 inputs reported · High confidence
Stronger than most peers on:
Revenue and earnings-per-share growth over one year, and revenue growth over three years.
3/3 inputs reported · High confidence
Stronger than most peers on:
Return on invested capital, operating margin, and return on assets.
3/3 inputs reported · High confidence
Stronger than most peers on:
Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Got stronger
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 101.7M USD | 106.7M USD | +4.9% |
| Net income (12 months) | −3.0M USD | 58.0M USD | turned positive |
| Operating margin | -15.8% | 1.6% | +17.5 pts |
| Free cash flow (12 months) | 8.4M USD | 8.1M USD | −3.8% |
| Debt | 2.5M USD | 0 USD | turned negative |
| Cash | 22.8M USD | 24.0M USD | +5.1% |
| Shares outstanding | 48.9M | 48.9M | +0.1% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Medical Instruments & Supplies are near the bottom of their range since Jul 2018.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Gross margin | — | — | 60.7% | 67.1% | 64.6% | ▼ 2.5 pts |
| Operating margin | -29.5% | -7.8% | -25.3% | -6.0% | -17.3% | ▼ 11 pts |
| Net margin | -7.5% | -183.4% | -100.0% | -27.0% | -4.8% | ▲ 22 pts |
| Return on assets (ROA) | -1.6% | -31.1% | -16.5% | -5.1% | -1.1% | ▲ 3.9 pts |
| Return on equity (ROE) | -1.9% | -38.4% | -20.1% | -5.8% | -1.2% | ▲ 4.5 pts |
| Free cash flow margin | -10.9% | -24.8% | -27.8% | 7.0% | 11.1% | ▲ 4.1 pts |
| Current ratio | 2.95× | 3.11× | 2.86× | 4.54× | 5.94× | ▲ 31% |
| Quick ratio | 2.29× | 2.32× | 2.22× | 3.66× | 4.63× | ▲ 27% |
| Debt to equity | 0.02× | 0.07× | 0.07× | 0.05× | 0.01× | ▼ 71% |
Price history is added with the daily price update and will appear after the next one.